Key result
Nasal stent placement is linked to ~6-fold higher odds of perioperative adverse events.
Why the study?
Patients undergoing palatoplasty experience perioperative adverse events, and identifying risk factors for these events and escalation of care may improve outcomes.
What are the risk factors for perioperative adverse events and care escalation in pediatric patients undergoing primary palatoplasty?
Observational (n=459)
Yes
What are the risk factors for perioperative adverse events and care escalation in pediatric patients undergoing primary palatoplasty?
Effect estimate: OR 6.02 (95% CI 2.7-13.6)
p-value: p=<0.001
Prolonged emergence time and nasal stent placement are significant risk factors for perioperative adverse events and unanticipated PICU admission in pediatric patients undergoing primary palatoplasty.
May warrant closer monitoring with nasal stents; leaves open whether avoidance reduces events in palatoplasty.
BACKGROUND: Patients undergoing palatoplasty experience perioperative adverse events. Identifying risk factors for perioperative adverse events and escalation of care may improve outcomes. METHODS: Pediatric patients undergoing primary palatoplasty were included in this retrospective observational study performed at two academic children's hospitals from 2014 to 2020. RESULTS: Four hundred fifty-nine patients with a median age of 12 months (IQR: 10-17) and median weight of 9.3 kg (IQR: 8.3-10.9) were included. A perioperative adverse event occurred in 15% (69/459) patients. Multiple (> 1) perioperative adverse events occurred in 18 patients. Hypoxemia (42 events, 9.2%) was the most common perioperative adverse event, followed by upper airway obstruction (29 events, 6.3%), vomiting (11 events, 2.4%), hypoventilation (10 events, 2.2%), and bleeding (7 events, 1.5%). Two events required a rapid response team, and there was 1 cardiac arrest. Forty percent of perioperative adverse events occurred in the post-anesthesia recovery area, and 24% occurred within 12 h of arriving to the floor. Prolonged emergence time (OR 1.04 [95% CI 1.02-1.06], p < 0.001) and nasal stent placement (OR 6.02 [95% CI 2.7-13.6], p < 0.001) were significantly associated with perioperative adverse events and increased odds of unanticipated admission to the pediatric intensive care unit (OR 1.02 [95% CI, 1.01-1.04], p < 0.001) and (OR 3.39 [95% CI, 1.19-8.83], p = 0.016), respectively. The occurrence of any perioperative adverse event (OR 8.47 [95% CI, 4.06-18], p < 0.001) and increasing number of perioperative adverse events (OR 1.75 [95% CI, 1.41-2.24], p < 0.001) were also associated with increased odds of unanticipated PICU admission. CONCLUSIONS: Patients undergoing palatoplasty are at risk of perioperative adverse events, particularly in post-operative recovery areas, which may result in unanticipated escalation of care. Recognizing the risk factors associated with the development of perioperative adverse events may improve planning of post-operative care and outcomes.
No takes yet. Share an insight, caveat, or question.
Padiyath et al. (2026) conducted an observational in Primary palatoplasty (n=459). Nasal stent placement and prolonged emergence time was evaluated on Perioperative adverse events (OR 6.02, 95% CI 2.7-13.6, p=<0.001). Nasal stent placement and prolonged emergence time were significantly associated with perioperative adverse events (OR 6.02; 95% CI 2.7-13.6; p<0.001 for nasal stent).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: